Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)

SHA:600594 Revenue

Guizhou Yibai Pharmaceutical had revenue of 330.55M CNY in the quarter ending June 30, 2026, a decrease of -32.77%. This brings the company's total for the last twelve months to 1.56B, down -22.00% year-over-year. In the year 2025, Guizhou Yibai Pharmaceutical had annual revenue of 1.86B, down -14.31%. That makes Guizhou Yibai Pharmaceutical the 16,306th largest company in the world by revenue and 2,931st in China.

• Revenue (ttm): 1.56B
• Revenue Growth: -22.00%
• P/S Ratio: 1.66
• Revenue / Employee: 322.68K
• Employees: 4,832
• Market Cap: 2.59B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Industry 1.45B 78.3%
• Medical Services 400.55M 21.7%

Fiscal year ended Dec 31, 2025 See the full SHA:600594 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.86B	-311.11M	-14.31%
Dec 31, 2024	2.17B	-646.53M	-22.92%
Dec 31, 2023	2.82B	85.30M	3.12%
Dec 31, 2022	2.74B	-611.44M	-18.27%
Dec 31, 2021	3.35B	-66.49M	-1.95%

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error